Morning Rounds: New Shingles Vaccine

The Morning Show

Dr. Daniel Deem from Christie Clinic joins the Morning Show and in this week’s Morning Rounds he is discussing a new shingles vaccine, Shingrix.

In October 2017, the FDA approved a new shingles vaccine, called Shingrix. 
This January, the CDC officially recommended that adults 50 and over get the new vaccine to prevent this painful, blistering disease instead of the previous one, Zostavax. WebMD asked a few infectious disease experts how Shingrix works and whether it has any risks.

Shingrix is more than 90% effective at preventing shingles and a painful complication called postherpetic neuralgia (PHN) in all age groups. Zostavax only lowers the odds of getting shingles by 51%, and of PHN by 67%. It’s even less effective in people ages 70 and older.

The CDC says healthy adults ages 50 and over should get the Shingrix vaccine. You should get it even if you’re not sure if you ever had chickenpox, the CDC says.  You need two doses, given 2 to 6 months apart. 

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Golf Tour Extravaganza 2020